Medicine and Dentistry
Acetic Acid Derivative
12%
Adult
14%
Age
28%
Albumin
18%
Association
42%
Body Mass Index
12%
Cardiovascular Disease
19%
Cardiovascular Risk
10%
Cardiovascular System
11%
Cells
24%
Combination Therapy
30%
Creatinine
22%
Diabetes
44%
Diabetes Mellitus
22%
Diabetic Nephropathy
18%
Fatty Liver
35%
Fibrosis
16%
Follow up
10%
Glucose
49%
Glycated Hemoglobin
12%
Glycemic
18%
Glycemic Control
11%
Glycon
29%
Glycosylated Albumin
42%
Hazard Ratio
12%
Health
15%
Hemoglobin A1c
48%
Homeostatic Model Assessment
11%
Hypoglycemia
14%
Inpatient
41%
Insulin
20%
Insulin Dependent Diabetes Mellitus
13%
Intima-Media Thickness
14%
Liver Fibrosis
26%
Man
10%
Marker
11%
Maturity Onset Diabetes of the Young
100%
Non-Alcoholic Fatty Liver Disease
10%
Nonalcoholic Fatty Liver
68%
Obesity
19%
Odds Ratio
27%
Oral Antidiabetic Agent
12%
Patient
82%
Patient with Type 2 Diabetes
63%
Sarcopenia
14%
Serum
18%
Sitagliptin
11%
Sodium Glucose Cotransporter 2 Inhibitor
21%
Therapeutic Procedure
40%
Urinary System
24%
Pharmacology, Toxicology and Pharmaceutical Science
Acetic Acid Derivative
5%
Antidiabetic Agent
7%
Bladder Cancer
5%
Combination Therapy
8%
Creatinine
12%
Dapagliflozin
8%
Dementia
12%
Diabetes Mellitus
36%
Diabetic Nephropathy
9%
Dipeptidyl Peptidase IV Inhibitor
20%
Dulaglutide
6%
Exendin 4
8%
Fat
5%
Fatty Liver
7%
Fatty Liver
6%
Gemigliptin
5%
Glimepiride
7%
Glucagon-Like Peptide-1
6%
Glucose
27%
Glycosylated Albumin
18%
Glycosylated Hemoglobin
6%
Heart Failure
5%
Hemoglobin A1c
39%
Hypoglycemia
5%
Hypoxia
5%
Incidence
7%
Insulin
16%
Insulin Resistance
5%
Lipid
8%
Liver Fibrosis
6%
Lobeglitazone
6%
Metformin
6%
Mouse
7%
Non Insulin Dependent Diabetes Mellitus
49%
Nonalcoholic Fatty Liver
20%
Obesity
5%
Oral Antidiabetic Agent
6%
Pioglitazone
18%
Protein
5%
Rat
8%
Rosiglitazone
7%
Sitagliptin
10%
Sodium Glucose Cotransporter 2 Inhibitor
10%
Statin (Protein)
6%
Sulfonylurea
13%
Teneligliptin
6%
Vasculotropin
5%
Vildagliptin
7%
Biochemistry, Genetics and Molecular Biology
Age
9%
Association
11%
Autophagy
12%
Body Mass
11%
C-Peptide
5%
Creatinine
10%
Delta-Like 1
6%
Development
10%
Dose
7%
Endothelial Progenitor Cell
6%
Fat
7%
Glucose
33%
Glucose Blood Level
8%
Glycation
6%
Glycemic Control
5%
Green Fluorescent Protein
5%
Homeostasis
5%
Insulin
24%
Insulin Resistance
9%
Lipoprotein Receptor-Related Protein
6%
Low-Density Lipoprotein
5%
Lysozyme
5%
Mouse
14%
Pioglitazone
6%
Protein
10%
Rat
5%
Reduction (Chemistry)
6%
Rosiglitazone
5%
Thiazolidinedione
5%
Weight
6%
